Epoetin alfa prevents, treats chemotherapy-induced anemia

07/19/2013 | MedPage Today (free registration)

Prophylactic epoetin alfa eased anemia during aggressive chemotherapy for breast cancer, a study found. However, 7% of the epoetin alfa-treated patients had thrombotic events, compared with 3% in a control group. "With the exception of this risk, erythropoiesis-stimulating agents appear to be safe drugs for the treatment of chemotherapy-induced anemia or the primary prevention of anemia in patients with intensive dose-dense chemotherapy regimens," according to the report in the Journal of the National Cancer Institute.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC